Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8

被引:64
作者
Carbone, A
Cilia, AM
Gloghini, A
Capello, D
Todesco, M
Quattrone, S
Volpe, R
Gaidano, G
机构
[1] Ctr Riferimento Oncol, IRCCS, Ist Nazl Tumori, Div Pathol, I-33081 Aviano, Italy
[2] Univ Turin, Dept Med Sci, Div Internal Med, Novara, Italy
关键词
primary effusion lymphoma cell lines; HHV-8-positive primary effusion lymphoma cell lines; AIDS-related non-Hodgkin's lymphoma; HHV-8; infection; EBV infection;
D O I
10.1046/j.1365-2141.1998.00877.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we report on the establishment and characterization of two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) which carry infection by human herpesvirus type-8 (HHV-8) and have derived from AIDS-related primary effusion lymphoma (PEL). These two cell lines are representative of different virologic subtypes of PEL, i.e. HHV-8(+)/EBV- PEL in the case of CRO-AP/3 and HHV-8(+)/EBV+ PEL in the case of CRO-AP/5. Consistent with the diagnosis of PEL, both CRO-AP/3 and CRO-AP/5 expressed indeterminate (i.e. non-B, non-T) phenotypes although immunogenotypic studies documented their B-cell origin, Both cell lines are devoid of genetic lesions of c-MYC, BCL-2 and p53 as well as gross rearrangements of BCL-6. Detailed histogenetic characterization of these novel PEL cell lines suggests that PEL may derive from a post-germinal centre B cell which has undergone pre-terminal differentiation. The CRO-AP/3 and CRO-AP/5 cell lines may provide a valuable model for clarifying the pathogenesis of PEL. In particular, these cell lines may help understand the relative contribution of HHV-8 and EBV to PEL growth and development and may facilitate the identification of recurrent cytogenetic abnormalities highlighting putative novel cancer related loci relevant to PEL.
引用
收藏
页码:1081 / 1089
页数:9
相关论文
共 35 条
  • [1] Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus
    Arvanitakis, L
    Mesri, EA
    Nador, RG
    Said, JW
    Asch, AS
    Knowles, DM
    Cesarman, E
    [J]. BLOOD, 1996, 88 (07) : 2648 - 2654
  • [2] BALLERINI P, 1993, BLOOD, V81, P166
  • [3] Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
    Boshoff, C
    Gao, SJ
    Healy, LE
    Matthews, S
    Thomas, AJ
    Coignet, L
    Warnke, RA
    Strauchen, JA
    Matutes, E
    Kamel, OW
    Moore, PS
    Weiss, RA
    Chang, Y
    [J]. BLOOD, 1998, 91 (05) : 1671 - 1679
  • [4] Carbone A, 1997, AM J PATHOL, V150, P155
  • [5] Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions
    Carbone, A
    Gloghini, A
    Vaccher, E
    Zagonel, V
    Pastore, C
    DallaPalma, P
    Branz, F
    Saglio, G
    Volpe, R
    Tirelli, U
    Gaidano, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) : 533 - 543
  • [6] Carbone A, 1997, INT J CANCER, V73, P562, DOI 10.1002/(SICI)1097-0215(19971114)73:4&lt
  • [7] 562::AID-IJC18&gt
  • [8] 3.0.CO
  • [9] 2-B
  • [10] HHV-8-positive body-cavity-based lymphoma: A novel lymphoma entity
    Carbone, A
    Gaidano, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) : 515 - 522